Anhui Huaheng holds a total of 249.72 Million outstanding shares. Anhui Huaheng Biotechnology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Anhui Huaheng in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Anhui Huaheng, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Anhui
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anhui Huaheng Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Anhui Stock Ownership Analysis
About 36.0% of the company shares are owned by insiders or employees . The book value of Anhui Huaheng was presently reported as 8.02. The company last dividend was issued on the 22nd of July 2024. Anhui Huaheng Biotec had 1.45:1 split on the 22nd of July 2024. For more info on Anhui Huaheng Biotechnology please contact the company at 86 551 6568 9170 or go to https://www.huahengbio.com.
Anhui Huaheng Outstanding Bonds
Anhui Huaheng issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Anhui Huaheng Biotec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Anhui bonds can be classified according to their maturity, which is the date when Anhui Huaheng Biotechnology has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Anhui Huaheng financial ratios help investors to determine whether Anhui Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Anhui with respect to the benefits of owning Anhui Huaheng security.